Search results
Peapack Gladstone Financial Corp Sells 143 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 6 hours agoPeapack Gladstone Financial Corp decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 4.8% during the fourth quarter, according to ...
...That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages...
Morningstar· 13 hours agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Biogen
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 2 days agoGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB) Glancy Prongay & Murray LLP (“GPM ...
Investors who lost money on Biogen Inc. (BIIB) should contact The Gross Law Firm about pending Class...
Morningstar· 1 day agoNEW YORK, June 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB). Shareholders who purchased ...
FINAL DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Encourages Investors in Biogen Inc. with...
Morningstar· 23 hours agoLOS ANGELES, June 5, 2024 /PRNewswire/ -- , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc
Biogen stock favored at RBC as Lilly awaits Alzheimer’s drug
Seeking Alpha· 21 hours agoRBC Capital Markets maintains a bullish view on Biogen (BIIB) despite Eli Lilly's (LLY) upcoming FDA...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 5 days agoNEW YORK, June 01, 2024 (GLOBE NEWSWIRE) -- Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc ...
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a...
Morningstar· 7 days agoBiogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained orphan ...
...ALERT: Robbins Geller Rudman & Dowd LLP Announces that Biogen, Inc. Investors with Substantial...
Benzinga· 4 days agoSAN DIEGO, June 02, 2024 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Biogen Inc. (NASDAQ:BIIB) securities between February 3, 2022 and February 13, 2024, both
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Benzinga via Yahoo Finance· 6 days agoOn Thursday, the European Commission granted marketing authorization under exceptional circumstances...